GenMark Diagnostics Schedules Second Quarter Financial Results Conference Call for July 30, 2018
July 16 2018 - 5:31PM
GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it
plans to release its second quarter earnings results after market
close on Monday, July 30, 2018. Management will hold a
conference call to review the Company's financial performance
starting at 4:30 p.m. ET on the same day. The conference
call will be concurrently webcast. The link to the webcast will be
available on the GenMark Diagnostics, Inc. website
at www.genmarkdx.com under the investor relations section
and will be archived for future reference. To listen to the
conference call, please dial (877) 312-5847 (US/Canada) or (253)
237-1154 (International) and use the conference ID number 4473539
approximately five minutes prior to the start time.
ABOUT GENMARK DIAGNOSTICS GenMark
Diagnostics (NASDAQ:GNMK) is a leading provider of multiplex
molecular diagnostic solutions designed to enhance patient care,
improve key quality metrics, and reduce the total cost-of-care.
Utilizing GenMark's proprietary eSensor® detection technology,
GenMark's eSensor XT-8® and ePlex® systems are designed to support
a broad range of molecular diagnostic tests with compact,
easy-to-use workstations and self-contained, disposable test
cartridges. GenMark’s ePlex: The True Sample-to-Answer Solution™ is
designed to optimize laboratory efficiency and address a broad
range of infectious disease testing needs, including respiratory,
bloodstream, and gastrointestinal infections. For more
information, visit www.genmarkdx.com.
Investor Relations Contact Lynn Pieper Lewis or
Leigh Salvo
(415) 937-5404
ir@genmarkdx.com
GenMark Diagnostics (NASDAQ:GNMK)
Historical Stock Chart
From Mar 2024 to Apr 2024
GenMark Diagnostics (NASDAQ:GNMK)
Historical Stock Chart
From Apr 2023 to Apr 2024